前往化源商城

5-甲基-3,4-吡啶二胺

更新时间:2025-08-28 01:14:21

5-甲基-3,4-吡啶二胺结构式
5-甲基-3,4-吡啶二胺结构式
品牌特惠专场
常用名 5-甲基-3,4-吡啶二胺 英文名 5-Methylpyridine-3,4-diamine
CAS号 13958-86-6 分子量 172.114
密度 1.5±0.1 g/cm3 沸点 402.9±40.0 °C at 760 mmHg
分子式 C6H5FN2O3 熔点 N/A
MSDS N/A 闪点 197.5±27.3 °C

 5-甲基-3,4-吡啶二胺名称

中文名 5-甲基-3,4-二氨基吡啶
英文名 5-methylpyridine-3,4-diamine
中文别名 3,4-二氨基-5-甲基吡啶 | 5-甲基-3,4-吡啶二胺
英文别名 更多

 5-甲基-3,4-吡啶二胺物理化学性质

密度 1.5±0.1 g/cm3
沸点 402.9±40.0 °C at 760 mmHg
分子式 C6H5FN2O3
分子量 172.114
闪点 197.5±27.3 °C
精确质量 172.028427
PSA 71.28000
LogP -0.35
蒸汽压 0.0±0.9 mmHg at 25°C
折射率 1.565
储存条件 2-8°C

 5-甲基-3,4-吡啶二胺安全信息

危害码 (欧洲) Xi
海关编码 2933399090

 5-甲基-3,4-吡啶二胺合成线路

~61%

5-甲基-3,4-吡啶二胺结构式

5-甲基-3,4-吡啶二胺

13958-86-6

文献:K.U. LEUVEN RESEARCH and DEVELOPMENT; GILEAD SCIENCES, INC.; PUERSTINGER, Gerhard Patent: WO2005/63744 A2, 2005 ; Location in patent: Page/Page column 232 ;

 5-甲基-3,4-吡啶二胺上下游产品

5-甲基-3,4-吡啶二胺上游产品  1

5-甲基-3,4-吡啶二胺下游产品  0

 5-甲基-3,4-吡啶二胺海关

海关编码 2933399090
中文概述 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期
Summary 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 5-甲基-3,4-吡啶二胺英文别名

5-Methyl-3,4-pyridinediamine
3,4-Diamino-5-methyl-pyridin
Pyridine, 3-fluoro-5-methyl-4-nitro-, 1-oxide
3-Methyl-4,5-diamino-pyridin
3,4-diamino-5-methylpyridine
3-Fluoro-5-methyl-4-nitropyridine 1-oxide
3-Methyl-4,5-diaminopyridine
5-methyl-pyridine-3,4-diamine
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。
品牌现货直购
推荐供应商:



查看所有供应商和价格请点击:

5-甲基-3,4-吡啶二胺生产厂家

5-甲基-3,4-吡啶二胺价格

相关化合物: 更多...
5-溴-n4-环丙基-3,4-吡啶二胺
607372-29-2
5-甲基-八氢-1H-吡咯并[3,4-c]吡啶二盐酸盐
1803598-04-0
5-甲氧基-2,3-吡啶二胺二盐酸盐
127356-15-4
5-甲氧基-6-甲基-3,4-吡啶二甲醇
633-72-7
5-甲基-4-硝基-2-吡啶胺
895520-03-3
5-甲基-1,2,4-噻唑-3,4-二胺
21532-07-0
N2-甲基-2,4-吡啶二胺
920520-39-4
N2-甲基-2,3-吡啶二胺
5028-20-6
6-甲基-5-硝基-2,4-吡啶二胺
2829-59-6
(2S,3R,6S,8R,15S,22S)-12-hydroxy-8-(2-hydroxypropan-2-yl)-2,3,23,23,25,25-hexamethyl-7,24-dioxa-31-azaoctacyclo[15.14.0.02,15.03,12.06,11.018,30.020,28.022,27]hentriaconta-1(17),10,18(30),19,26,28-hexaen-9-one
163136-25-2
(3R,7'R,9'S)-7,7,10',10'-tetramethylspiro[1H-pyrano[2,3-g]indole-3,11'-3,13-diazatetracyclo[5.5.2.01,9.03,7]tetradecane]-2,2',14'-trione
1134155-01-3
Erinacine I
197640-46-3
rel-(2aR,5aR,6S,9R,9aS,10aS,12S,12aR)-2a,6,9,9a,10,10a,11,12-Octahydro-6-hydroxy-7-(hydroxymethyl)-2,10,10,12-tetramethyl-9,12a-methano-12aH-cyclopropa[7a(2),8a(2)]cyclodeca[1a(2),2a(2):1,5]cyclopenta[1,2-d][1,3]dioxole-4,13-dione
501418-23-1
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl]amino]-7-methoxy-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-, [6R-(6I+/-,7I+/-)]-
69712-57-8
2-Butenoic acid, 2-methyl-, (1R,2a(2)R,3R,4aR,5S,6R,8S,8aR)-8-(acetyloxy)-5-[(2S,3aR,6aS)-hexahydrofuro[2,3-b]furan-2-yl]hexahydro-5,6-dimethylspiro[3H-3,8a-ethano-1H-2-benzopyran-9,2a(2)-oxiran]-1-yl ester, (2E)-
151200-61-2
Cyclopropanecarboxylic acid, 1-[(2E,4R)-4-[octahydro-7a-methyl-4-[(2E)-2-[(3S,5R)-2-methylene-3,5-bis(1,1,2,2-tetramethylpropoxy)cyclohexylidene]ethylidene]-1H-inden-1-yl]-1-oxo-2-penten-1-yl]-, methyl ester
1260505-02-9
1-Phenanthrenecarboxylic acid, 2,9-bis(acetyloxy)-7-[2-[[2-(acetyloxy)ethyl]methylamino]-2-oxoethylidene]tetradecahydro-1,4a,8-trimethyl-10-oxo-, methyl ester, [1R-(1I+/-,2I+/-,4aI+/-,4bI(2),7E,8I(2),8aI+/-,9I+/-,10aI(2))]-
58811-95-3
7-[[4-[[1-Amino-2-(formyloxy)-1-methylethyl]amino]-6-[(2-aminopropyl)amino]-1,3,5-triazin-2-yl]amino]-6-[2-[4-(aminosulfonyl)-2-methoxy-6-methylphenyl]diazenyl]-4-hydroxy-2-naphthalenesulfonic acid
784157-49-9
Carbamic acid, [1-[2-[[2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3,3,3-trifluoro-1-(1-methylethyl)propyl]amino]-2-oxoethyl]-1,2-dihydro-2-oxo-6-phenyl-3-pyridinyl]-, 1-methyl-4-piperidinyl ester
147284-03-5